GZBX - Genzyme Biosurgery | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
GZBX - Genzyme Biosurgery

An SI Board Since January 2001

Posts	SubjectMarks	Bans	Symbol
18	5	0	GZBX

Emcee: Spekulatius	Type: Unmoderated

Introduction Market Data Compact

Genzyme Biosurgery is engaged in the manufacturing, development and marketing of biotechnology products that attempt to improve and/or replace surgery. GZBX is developing technologies to grow tissues and organs in vitro for implantation to replace diseased or aged body parts.

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
18	Good News: biz.yahoo.com	Dave Feldman	-	10/1/2002
17	Based on the numbers below, I conclude that cash burn is about 11M$/quarter. Ext	Spekulatius	-	1/16/2002
16	"GZBX has a cash burn of about 20M$ per quarter." Perhaps the $20m in	Extra Pale	-	1/15/2002
15	GZBX has a cash burn of about 20M$ per quarter. They have about 40M$ in cash ply	Spekulatius	-	1/15/2002
14	Doing some dd on gzbx today and noted that $20m payment to genz for neurocell pr	Extra Pale	-	1/12/2002
13	Monday June 4, 10:06 am Eastern Time Press Release SOURCE: Genzyme Corp. Genzy	betone	-	6/5/2001
12	Thursday May 31, 10:24 am Eastern Time Press Release SOURCE: Genzyme Corp. Ge	betone	-	5/31/2001
11	The yearly meeting of colorectal surgeons starts this weekend in San Diego and G	RRICH4	-	5/30/2001
10	Spek, I also started accumulating GZBX. It will be interesting to see how long	Joan Osland Graffius	-	4/9/2001
9	>>GZBX at 4$ would be a terrific price.<< I have established a posit	Spekulatius	-	4/9/2001
8	Genzyme and Diacrin Report Preliminary Results From Phase 2 Trial of NeuroCell(T	KLH	-	3/16/2001
7	GZBX restructuring: It seems that GZBX management is moving in the right directi	Spekulatius	-	2/19/2001
6	Gzbx: The issue is revenue. I think the revenue is severly overstated and that	valueminded	-	2/11/2001
5	Spec, >>GZBX at 4$ would be a terrific price. I agree. <g> OT. I	Joan Osland Graffius	-	2/11/2001
4	GZBX at 4$ would be a terrific price. The company would have a market cap of 150	Spekulatius	-	2/11/2001
3	Spek, I am watching this one also. I am cheap and waiting for the $4 + or - for	Joan Osland Graffius	-	2/11/2001
2	<< Anybody Home???>> Obviously not. This company is indeed very very	Spekulatius	-	2/11/2001
1	Anybody Home??? Where is the news on this company? It sure is one hell of a di	Exacctnt	-	2/9/2001

Go to reply# or date (mm/dd/yy):